GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a major focus in therapeutic investigation, largely due to its impressive impact on managing diseases such as type 2 diabetes and excess body fat. Recent research have shown that more than glucose control, GLP-1 drugs offer promise for heart well-being and even brain co